RecruitingNot ApplicableNCT07471685

Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors

Development and Pilot Testing of a Family Building Decision Support Intervention for Female Adolescent and Young Adult Cancer Survivors

Sponsor

Duke University

Enrollment

48 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

Cancer Survivorship Family Planning Adolescent and Young Adult Cancer

Summary

This study aims to develop and pilot-test a nurse navigator-delivered behavioral program to support female adolescent and young adult (AYA) cancer survivors in making informed, values-driven family-building decisions after completion of cancer treatment. Female AYA survivors often face fertility impairments, uncertainty about reproductive potential, elevated obstetric risks during pregnancy, and significant emotional distress related to parenthood planning. Currently, few interventions address these post-treatment decision-making needs. The intervention consists of four videoconference sessions that combine personalized, risk-based reproductive health education with coping strategies derived from Acceptance and Commitment Therapy and Patient Activation Theory. A pilot randomized controlled trial will evaluate feasibility, acceptability, and preliminary changes in knowledge, decisional conflict, self-efficacy, and reproductive-health-related distress among 48 participants randomized to the intervention or a survivorship-education control condition. Findings will inform future testing of the intervention's efficacy in a larger clinical trial.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 39 Years

Inclusion Criteria6

Female (biological sex) AYA cancer survivor age 15-39 at original diagnosis and 18-39 at enrollment.
Completed cancer treatment with curative intent.
Prior exposure to treatments posing gonadotoxic risk (e.g., alkylating agents, total body irradiation) and/or treatments increasing obstetric risk (e.g., chest radiation, radiation to uterus, anthracycline exposure).
Has not completed family building.
Able to speak/read English.
Willing and able to complete videoconference sessions and REDCap surveys.

Exclusion Criteria1

Visual, hearing, or cognitive impairment or severe mental illness that would interfere with participation as determined by study staff.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALNurse Navigator-Delivered Family Building Decision Support

Four \~60-minute, weekly or biweekly videoconference sessions over 4-6 weeks. Components include: Personalized, risk-based reproductive health education based on cancer type and treatment exposures (e.g., gonadotoxic chemotherapy, chest or uterine radiation, anthracyclines); review of fertility potential evaluation, assisted reproductive technologies, adoption pathways, and pregnancy health considerations (maternal/fetal risks, surveillance, co-management). ACT-derived coping skills (values clarification, cognitive defusion, acceptance, committed action) to align decisions with personal values and reduce avoidance. Patient activation strategies to promote engagement in risk-based reproductive care and informed decision-making. Includes between-session practice and brief home exercises.

BEHAVIORALSurvivorship Education

NCI booklet "Facing Forward: Life After Cancer Treatment" provided at baseline; participants may receive referrals to survivorship supportive services as needed.